These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2540533)

  • 1. Safety and tolerance of Navelbine in phase I-II clinical studies.
    Besenval M; Delgado M; Demarez JP; Krikorian A
    Semin Oncol; 1989 Apr; 16(2 Suppl 4):37-40. PubMed ID: 2540533
    [No Abstract]   [Full Text] [Related]  

  • 2. Navelbine in advanced ovarian epithelial cancer: a study of the French oncology centers.
    George MJ; Heron JF; Kerbrat P; Chauvergne J; Goupil A; Lebrun D; Guastalla JP; Namer M; Bugat R; Ayme Y
    Semin Oncol; 1989 Apr; 16(2 Suppl 4):30-2. PubMed ID: 2652318
    [No Abstract]   [Full Text] [Related]  

  • 3. Efficacy of Navelbine (NVB) in non-small cell lung cancer (NSCLC).
    Depierre A; Lemarie E; Dabouis G; Garnier G; Jacoulet P; Dalphin JC
    Semin Oncol; 1989 Apr; 16(2 Suppl 4):26-9. PubMed ID: 2540532
    [No Abstract]   [Full Text] [Related]  

  • 4. Phase-II study of Navelbine in advanced breast cancer.
    Canobbio L; Boccardo F; Pastorino G; Brema F; Martini C; Resasco M; Santi L
    Semin Oncol; 1989 Apr; 16(2 Suppl 4):33-6. PubMed ID: 2711204
    [No Abstract]   [Full Text] [Related]  

  • 5. Oral vinorelbine (Navelbine) in the treatment of advanced non-small cell lung cancer: a preliminary report.
    Vokes EE; Rosenberg R; Jahanzeb M; Craig J; Gralla R; Belani C; Jones S; Bigley J; Hohneker J
    Semin Oncol; 1994 Oct; 21(5 Suppl 10):35-8; discussion 38-41. PubMed ID: 7973767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phase II trail of vindesine in patients with refractory small-cell carcinoma of the lung.
    Fuks JZ; Aisner J; Carney DN; Van Echo DA; Ostrow SS; Ihde DC; Wiernik PH
    Am J Clin Oncol; 1982 Feb; 5(1):49-52. PubMed ID: 6282108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pilot study of vinorelbine (navelbine) and paclitaxel in patients with refractory non-small cell lung cancer.
    Chang AY; DeVore R; Johnson D
    Semin Oncol; 1996 Apr; 23(2 Suppl 5):19-21. PubMed ID: 8610231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A summary of vinorelbine (Navelbine) safety data from North American clinical trials.
    Hohneker JA
    Semin Oncol; 1994 Oct; 21(5 Suppl 10):42-6; discussion 46-7. PubMed ID: 7973769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Studies of the clinical use of cycloplatin--a new derivative of cisplatin].
    Koralewski P; Pawlicki M
    Przegl Lek; 1992; 49(4):120-2. PubMed ID: 1332130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Phase II study of vindesine in patients with primary bronchogenic carcinoma by Cooperative Study Group].
    Gan To Kagaku Ryoho; 1983 Aug; 10(8):1838-43. PubMed ID: 6882007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A phase II study of cisplatin, 5-fluorouracil, and leucovorin augmented by vinorelbine (Navelbine) for advanced non-small cell lung cancer: rationale and study design.
    Vokes EE; Drinkard LC; Samuels BL; Hoffman PC; Watson S; Bitran JD; Haraf DJ; Ferguson MF; Golomb HM
    Semin Oncol; 1994 Oct; 21(5 Suppl 10):79-83; discussion 83-4. PubMed ID: 7973772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [1st experiences in the treatment of ovarian tumors with Peptichemio].
    Natale N; Mangioni C; Remotti G
    Minerva Med; 1974 May; 65(33):1805-10. PubMed ID: 4367233
    [No Abstract]   [Full Text] [Related]  

  • 13. A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas.
    Colón-Otero G; Marschke R; Camoriano JK; Sorensen JM; Sloan JA; Richardson RL
    Cancer J Sci Am; 1997; 3(5):297-302. PubMed ID: 9327154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Navelbine. Current and perspective aspects. International congress of Biarritz (November 1989)].
    Armand JP
    Bull Cancer; 1990; 77(8):841-5. PubMed ID: 2169931
    [No Abstract]   [Full Text] [Related]  

  • 15. Phase II evaluation of vindesine in patients with advanced breast cancer.
    Currie VE; Camacho F; Wittes R; Young C
    Cancer Treat Rep; 1980; 64(4-5):693-95. PubMed ID: 7427954
    [No Abstract]   [Full Text] [Related]  

  • 16. Phase II evaluation of vindesine in non-small cell bronchogenic carcinoma.
    Hutcheon AW; Palmer JB; Pratt MA; Clark RA
    Cancer Treat Rep; 1983 Nov; 67(11):1041-2. PubMed ID: 6315231
    [No Abstract]   [Full Text] [Related]  

  • 17. Vinorelbine (Navelbine)/carboplatin combination therapy: dose intensification with granulocyte colony-stimulating factor.
    Crawford J; O'Rourke MA
    Semin Oncol; 1994 Oct; 21(5 Suppl 10):73-8. PubMed ID: 7526467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vinorelbine (Navelbine) in non-small cell lung cancer: future directions.
    Crawford J
    Semin Oncol; 1994 Oct; 21(5 Suppl 10):85-8. PubMed ID: 7526468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cisplatin and ifosfamide with various doses of vinorelbine (navelbine) in advanced non-small lung cancer.
    Souquet PJ; Fournel P; Bohas CH; Fortune IC; Chatte G
    Semin Oncol; 1996 Apr; 23(2 Suppl 5):8-10. PubMed ID: 8610239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cytostatic treatment of lymphogranulomatosis. Experiences with ibenzmethyzine, cyclophosphamide and vinblastine sulfate].
    Schubert JC; Martin H
    Munch Med Wochenschr; 1968 Jan; 110(2):97-100. PubMed ID: 5695132
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.